The prevalences of salmonella genomic island 1 variants in human and animal Salmonella typhimurium DT104 are distinguishable using a Bayesian approach

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Mather, Alison E ^a,c   Denwood, Matthew J ^a   Haydon, Daniel T ^a   Matthews, Louise ^a   Mellor, Dominic J ^a   Coia, John E ^b   Brown, Derek J ^b   Reid, Stuart W J ^a,d  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b STOBHILL HOSPITAL   (United Kingdom)

^c WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^d ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CHLORAMPHENICOL; SPECTINOMYCIN; STREPTOMYCIN; SULFONAMIDE; TETRACYCLINE; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; BAYES THEOREM; DISEASE SURVEILLANCE; DOMESTIC ANIMAL; GENE IDENTIFICATION; GENETIC VARIABILITY; GENOMIC ISLAND; GENOTYPE PHENOTYPE CORRELATION; MICROBIAL GENETICS; MOLECULAR GENETICS; NONHUMAN; PHENOTYPE; PREVALENCE; SALMONELLA GENOMIC ISLAND 1; SALMONELLA TYPHIMURIUM; SALMONELLA TYPHIMURIUM DT104; SPECIES COMPARISON; ANIMAL; ANIMAL SALMONELLOSIS; CLASSIFICATION; DRUG EFFECT; GENE FREQUENCY; GENETICS; HUMAN; MICROBIOLOGY; MONTE CARLO METHOD; MULTIDRUG RESISTANCE; PROBABILITY; SALMONELLOSIS; SPECIES DIFFERENCE;

ANIMALIA; SALMONELLA; SALMONELLA TYPHIMURIUM;

ANIMALS; ANTI-BACTERIAL AGENTS; BAYES THEOREM; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENE FREQUENCY; GENETIC VARIATION; GENOMIC ISLANDS; HUMANS; MARKOV CHAINS; MONTE CARLO METHOD; SALMONELLA INFECTIONS; SALMONELLA INFECTIONS, ANIMAL; SALMONELLA TYPHIMURIUM; SPECIES SPECIFICITY;

EID: 81355142711     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027220     Document Type: Article

References (39)

1. Threlfall EJ, (2000) Epidemic Salmonella Typhimurium DT 104-a truly international multiresistant clone. J Antimicrob Chemother 46: 7-10.
2. Helms M, Ethelberg S, Molbak K, (2005) International Salmonella Typhimurium DT104 infections, 1992-2001. Emerg Infect Dis 11: 859-867.
3. Calvert N, Stewart WC, Reilly WJ, (1998) Salmonella Typhimurium DT104 infection in people and animals in Scotland: a collaborative epidemiological study 1993-96. Vet Rec 143: 351-354.
4. Fone DL, Barker RM, (1994) Associations between human and farm animal infections with Salmonella Typhimurium DT104 in Herefordshire. Commun Dis Rep CDR Rev 4: R136-140.
5. Wall PG, Morgan D, Lamden K, Griffin M, Threlfall EJ, et al. (1995) Transmission of multi-resistant strains of Salmonella Typhimurium from cattle to man. Vet Rec 136: 591-592.
6. Besser TE, Goldoft M, Pritchett LC, Khakhria R, Hancock DD, et al. (2000) Multiresistant Salmonella Typhimurium DT104 infections of humans and domestic animals in the Pacific Northwest of the United States. Epidemiol Infect 124: 193-200.
7. Mølbak K, Baggesen DL, Aarestrup FM, Ebbesen JM, Engberg J, et al. (1999) An outbreak of multidrug-resistant, quinolone-resistant Salmonella enterica serotype Typhimurium DT104. N Engl J Med 341: 1420-1425.
8. Wright JG, Tengelsen LA, Smith KE, Bender JB, Frank RK, et al. (2005) Multidrug-resistant Salmonella Typhimurium in four animal facilities. Emerg Infect Dis 11: 1235-1241.
9. Angulo FJ, Nargund VN, Chiller TC, (2004) Evidence of an association between use of anti-microbial agents in food animals and anti-microbial resistance among bacteria isolated from humans and the human health consequences of such resistance. J Vet Med B Infect Dis Vet Public Health 51: 374-379.
10. Glynn MK, Bopp C, Dewitt W, Dabney P, Mokhtar M, et al. (1998) Emergence of multidrug-resistant Salmonella enterica serotype Typhimurium DT104 infections in the United States. N Engl J Med 338: 1333-1339.
11. Mølbak K, (2004) Spread of resistant bacteria and resistance genes from animals to humans-the public health consequences. J Vet Med B Infect Dis Vet Public Health 51: 364-369.
12. Threlfall EJ, Frost JA, Ward LR, Rowe B, (1996) Increasing spectrum of resistance in multiresistant Salmonella Typhimurium. Lancet 347: 1053-1054.
13. Threlfall EJ, Ward LR, Rowe B, (1997) Increasing incidence of resistance to trimethoprim and ciprofloxacin in epidemic Salmonella Typhimurium DT104 in England and Wales. Euro Surveill 2: 81-84.
14. Boyd DA, Peters GA, Ng L, Mulvey MR, (2000) Partial characterization of a genomic island associated with the multidrug resistance region of Salmonella enterica Typhimurium DT104. FEMS Microbiol Lett 189: 285-291.
15. Levings RS, Lightfoot D, Partridge SR, Hall RM, Djordjevic SP, (2005) The genomic island SGI1, containing the multiple antibiotic resistance region of Salmonella enterica serovar Typhimurium DT104 or variants of it, is widely distributed in other S. enterica serovars. J Bacteriol 187: 4401-4409.
16. Poppe C, Ziebell K, Martin L, Allen K, (2002) Diversity in antimicrobial resistance and other characteristics among Salmonella Typhimurium DT104 isolates. Microb Drug Resist 8: 107-122.
17. Denwood MJ, Mather AE, Haydon DT, Matthews L, Mellor DJ, et al. (2010) From phenotype to genotype: a Bayesian solution. Proc R Soc B doi:10.1098/rspb.2010.1719.
18. Le Minor L, (1984) Genus III Salmonella. In: Krieg NR, Holt JG, editors. Bergey's Manual of Systematic Bacteriology Volume 1 Baltimore, London Williams and Wilkins pp. 427-458.
19. Callow BR, (1959) A new phage typing scheme for Salmonella typhimurium. J Hyg 57: 346-359.
20. Ward LR, de Sa JDH, Rowe B, (1987) A phage typing scheme for Salmonella enteriditis. Epidemiol Infect 99: 291-294.
21. Browning LM, Brown DJ, Coia JE, Cowden JM, Mather H, (2007) Antimicrobial resistance of Salmonella in Scotland, 2005. HPS Weekly Report 41: 172-176.
22. Boyd D, Cloeckaert A, Chaslus-Dancla E, Mulvey MR, (2002) Characterization of variant Salmonella genomic island 1 multidrug resistance regions from serovars Typhimurium DT104 and Agona. Antimicrob Agents Chemother 46: 1714-1722.
23. Boyd D, Peters GA, Cloeckaert A, Boumedine KS, Chaslus-Dancla E, et al. (2001) Complete nucleotide sequence of a 43-kilobase genomic island associated with the multidrug resistance region of Salmonella enterica serovar Typhimurium DT104 and its identification in phage type DT120 and serovar Agona. J Bacteriol 183: 5725-5732.
24. Carattoli A, Filetici E, Villa L, Dionisi AM, Ricci A, et al. (2002) Antibiotic resistance genes and Salmonella genomic island 1 in Salmonella enterica serovar Typhimurium isolated in Italy. Antimicrob Agents Chemother 46: 2821-2828.
25. Guerra B, Junker E, Miko A, Helmuth R, Mendoza MC, (2004) Characterization and localization of drug resistance determinants in multidrug-resistant, integron-carrying Salmonella enterica serotype Typhimurium strains. Microb Drug Resist 10: 83-91.
26. Miko A, Pries K, Schroeter A, Helmuth R, (2005) Molecular mechanisms of resistance in multidrug-resistant serovars of Salmonella enterica isolated from foods in Germany. J Antimicrob Chemother 56: 1025-1033.
27. Nielsen EM, Torpdahl M, Ethelberg S, Hammerum AM, (2009) Variation in antimicrobial resistance in sporadic and outbreak-related Salmonella enterica serovar Typhimurium. Emerg Infect Dis 15: 101-103.
28. Targant H, Doublet B, Aarestrup FM, Cloeckaert A, Madec J-Y, (2010) IS6100-mediated genetic rearrangement within the complex class 1 integron In104 of the Salmonella genomic island 1. J Antimicrob Chemother 65: 1543-1545.
29. Targant H, Ponsin C, Brunet C, Doublet B, Cloeckaert A, et al. (2010) Characterization of resistance genes in multidrug-resistant Salmonella enterica serotype Typhimurium isolated from diseased cattle in France (2002 to 2007). Foodborne Pathog Dis 7: 419-425.
30. Vo AT, van Duijkeren E, Fluit AC, Wannet WJ, Verbruggen AJ, et al. (2006) Antibiotic resistance, integrons and Salmonella genomic island 1 among non-typhoidal Salmonella serovars in The Netherlands. Int J Antimicrob Agents 28: 172-179.
31. Vo ATT, van Duijkeren E, Fluit AC, Gaastra W, (2007) A novel Salmonella genomic island 1 and rare integron types in Salmonella Typhimurium isolates from horses in The Netherlands. J Antimicrob Chemother 59: 594-599.
32. Weill FX, Guesnier F, Guibert V, Timinouni M, Demartin M, et al. (2006) Multidrug resistance in Salmonella enterica serotype Typhimurium from humans in France (1993 to 2003). J Clin Microbiol 44: 700-708.
33. Angulo FJ, Johnson KR, Tauxe RV, Cohen ML, (2000) Origins and consequences of antimicrobial-resistant nontyphoidal Salmonella: implications for the use of fluoroquinolones in food animals. Microb Drug Resist 6: 77-83.
34. Threlfall EJ, Frost JA, Ward LR, Rowe B, (1994) Epidemic in cattle and humans of Salmonella typhimurium DT 104 with chromosomally integrated multiple drug resistance. Vet Rec 134: 577-.
35. Wall PG, Morgan D, Lamden K, Ryan M, Griffin M, et al. (1994) A case control study of infection with an epidemic strain of multiresistant Salmonella Typhimurium DT104 in England and Wales. Commun Dis Rep CDR Rev 4: R130-135.
36. Briggs CE, Fratamico PM, (1999) Molecular characterization of an antibiotic resistance gene cluster of Salmonella Typhimurium DT104. Antimicrob Agents Chemother 43: 846-849.
37. Wiesner M, Zaidi M, Calva E, Fernandez-Mora M, Calva J, et al. (2009) Association of virulence plasmid and antibiotic resistance determinants with chromosomal multilocus genotypes in Mexican Salmonella enterica serovar Typhimurium strains. BMC Microbiol 9: 131.
38. Greene SK, Stuart AM, Medalla FM, Whichard JM, Hoekstra RM, et al. (2008) Distribution of multidrug-resistant human isolates of MDR-ACSSuT Salmonella Typhimurium and MDR-AmpC Salmonella Newport in the United States, 2003-2005. Foodborne Pathog Dis 5: 669-680.
39. Threlfall EJ, Teale CJ, Davies RH, Ward LR, Skinner JA, et al. (2003) A comparison of antimicrobial susceptibilities in nontyphoidal salmonellas from humans and food animals in England and Wales in 2000. Microb Drug Resist 9: 183-189.